Local Institution

Wilmington, North Carolina

0 studies enrolling now · 13 studies all time

What they study most

Arthritis, Rheumatoid, Diabetes Mellitus, Diabetes Mellitus, Type 2, Hypertension, Metabolics Diabetes Nos, Non-Small-Cell Lung Carcinoma, Rheumatoid Arthritis, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients — Completed
• PPAR - Combination With Metformin — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
• PPAR-COMBO With Sulfonylurea — Completed
• A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed